Table:
begin	end	state
1	33	non-cytoplasmic
34	57	transmembrane
58	87	cytoplasmic
88	110	transmembrane
111	115	non-cytoplasmic
116	133	transmembrane
134	176	cytoplasmic
177	199	transmembrane
200	218	non-cytoplasmic
219	238	transmembrane
239	244	cytoplasmic
245	266	transmembrane
267	280	non-cytoplasmic
281	303	transmembrane
304	340	cytoplasmic
341	361	transmembrane
362	395	non-cytoplasmic
396	418	transmembrane
419	436	cytoplasmic
437	457	transmembrane
458	462	non-cytoplasmic
463	480	transmembrane
481	505	cytoplasmic

Input:
>WP_211240420.1 NCBI__GCF_000527155.1:WP_211240420.1
MNFLDEFGSKLEEWVNSATAPIEGVVSATSTFVWGPFLLIPLLLGAGIILTSALGGIQFR
RLGYGLWLAFFKRHEARDTEGDISHYQALSVALAATVGVGNIGGVAAAFTLGGPGALFWM
WITGLLGMATKYSEALLGVKYRTVNEHGEQSGGPQQYLTRGLADITYLSEPVKKRIGAIL
GLSFAVFGVVASFGIGNALQSGNVSSAITGQWEGVDNSLVGIIMMVVAGLVILGGIKWIG
RVTSLFVPFMIVLYIAGTLAVLILNIDQLGAALNSIFSDAFTGSSAVGGFVGAGIITVVR
AGVARGIFSNESGLGTGGIAAAAAKTDAAPRQAMVSMTQTFIDTIIVVTLTGLTIAVTGV
LGTERVNDDGETVMVEGADLTRLAFEEGLSGWGDAGGLIVALAVVLFAMSTIFGWSYYGE
KCLERFAGDRFKLLYRTLFVLVVFVGAVTSLDVLWGISDVFNGLMAIPNLIGLIMLTPIL
RKETSKFFSNRDWRLLPTDALEKNG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server